WINLEVI

Peak

clascoterone

NDATOPICALCREAM
Approved
Aug 2020
Lifecycle
Peak
Competitive Pressure
8/100

Mechanism of Action

Androgen Receptor Antagonists

Pharmacologic Class:

Androgen Receptor Inhibitor

Loss of Exclusivity

LOE Date
Jul 25, 2030
53 months away
Patent Expiry
Jul 25, 2030

Patent Records (5)

Patent #ExpiryTypeUse Code
8143240
Jan 12, 2027
U-2942
11938141
Jul 24, 2028
Product
12337002
Jul 24, 2028
Product
U-3280
9486458
Jul 24, 2028
U-2942
10159682
Aug 14, 2028
U-2942